Epidemiology and clinical presentation of gonorrhoea in England and Wales: findings from the Gonococcal Resistance to Antimicrobials Surveillance Programme 2001-2006

被引:17
作者
Delpech, V. [1 ]
Martin, I. M. C. [1 ]
Hughes, G. [1 ]
Nichols, T. [1 ]
James, L. [1 ]
Ison, C. A. [1 ]
机构
[1] Hlth Protect Agcy, Ctr Infect, Sexually Transmitted Bacteria Reference Lab, London NW9 5EQ, England
关键词
SEXUALLY-TRANSMITTED INFECTIONS; HOMOSEXUAL-MEN; NEISSERIA-GONORRHOEAE; RISK BEHAVIOR; LONDON; PREVENTION; HIV; PREVALENCE; CHLAMYDIA; BRITAIN;
D O I
10.1136/sti.2008.034843
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: To analyse the enhanced data for gonorrhoea cases in England and Wales collected by the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) to better inform health policy and targeted interventions. Methods: GRASP data obtained annually from sentinel genitourinary medicine (GUM) clinics between June to August during 2001-6 were analysed. Results: A total of 12 282 cases of gonorrhoea were reported during the study period, with a decline over time primarily in heterosexual patients of black ethnicity. 73% of women, 47% of heterosexual men and 22% of men who have sex with men (MSM) were aged under 25. Most infected women reported a single sexual partner in the previous 3 months, whereas most heterosexual men and MSM reported two or more partners. A history of gonorrhoea was reported by 42% of MSM, 30% of heterosexual men and 20% of women. Excluding HIV, women were more likely than men to have a concurrent STI at diagnosis, most commonly chlamydia (50% vs 27% p<0.0005). Rectal gonococcal infections were reported in 35% and HIV co-infection in 31% of MSM. Compared to HIV negative MSM, those co-infected with HIV were older (median 35 years vs 28 years) and were more likely to attend a London site (70% vs 52%, p<0.0005); have a concurrent sexually transmitted infection ( STI) (28% vs 20%, p=0.002); have a history of gonorrhoea (66% vs 36%, p<0.0005) and have more sexual partners (average 6.8 vs 4.3). Conclusion: Gonorrhoea is concentrated within specific groups who are at high risk of repeat infections and concurrent STIs including HIV. Targeted interventions of proved effectiveness are urgently required.
引用
收藏
页码:317 / 321
页数:5
相关论文
共 27 条
[1]  
[Anonymous], BETT PREV BETT SERV
[2]  
*BASHH CLIN EFF GR, 2005, NAT GUID DIAGN TREAT
[3]   Identification of individuals with gonorrhoea within sexual networks: a population-based study [J].
Choudhury, Bhudipa ;
Risley, Claire L. ;
Ghani, Azra C. ;
Bishop, Cynthia J. ;
Ward, Helen ;
Fenton, Kevin A. ;
Ison, Catherine A. ;
Spratt, Brian G. .
LANCET, 2006, 368 (9530) :139-146
[4]   Increase in high risk sexual behaviour among homosexual men, London 1996-8: cross sectional, questionnaire study [J].
Dodds, JP ;
Nardone, L ;
Mercey, DE ;
Johnson, AM .
BRITISH MEDICAL JOURNAL, 2000, 320 (7248) :1510-1511
[5]   Trends in sexual behaviour among London homosexual men 1998-2003: implications for HIV prevention and sexual health promotion [J].
Elford, J ;
Bolding, G ;
Davis, M ;
Sherr, L ;
Hart, G .
SEXUALLY TRANSMITTED INFECTIONS, 2004, 80 (06) :451-454
[6]   Strategies for syphilis prevention - Findings from surveys in a high-incidence area [J].
Farley, TA ;
Kahn, RH ;
Johnson, G ;
Cohen, DA .
SEXUALLY TRANSMITTED DISEASES, 2000, 27 (06) :305-310
[7]   Reported sexually transmitted disease clinic attendance and sexually transmitted infections in britain: Prevalence, risk factors, and proportionate population burden [J].
Fenton, KA ;
Mercer, CH ;
Johnson, AM ;
Byron, CL ;
McManus, S ;
Erens, B ;
Copas, AJ ;
Nanchahal, K ;
Macdowall, W ;
Wellings, K .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 :S127-S138
[8]   Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002 [J].
Fenton, KA ;
Ison, C ;
Johnson, AP ;
Rudd, E ;
Soltani, M ;
Martin, I ;
Nichols, T ;
Livermore, DM .
LANCET, 2003, 361 (9372) :1867-1869
[9]   Increase in HIV sexual risk behaviour in homosexual men in Scotland, 1996-2002: prevention failure? [J].
Hart, GJ ;
Williamson, LM .
SEXUALLY TRANSMITTED INFECTIONS, 2005, 81 (05) :367-372
[10]  
*HLTH PROT AG, WAIT TIM GEN MED CLI